Christina Lake Cannabis Corp. CLCFF CLC revenue in Q2 2022 was CA$2.3 million ($1.8 million), a 40% increase over Q1 FY2022 and 971% over Q2 2021.
Q2 Financial Highlights
-
Gross Margin Before Fair Value Adjustments was 56% in Q2 FY2022 compared to 55% in Q1 FY2022 and 67% in Q2 FY2021.
-
Total general & administrative expenses declined by 70% in Q2 FY2022 compared to in Q2 FY2021, driven by year-over-year reductions in corporate development, marketing, and share based compensation expenses.
-
Net Income Q2 FY2022 was CA$22,000 which is a CA$1.8 million increase from the net loss incurred in Q2 FY2022. The year-over-year improvement is primarily driven by significant revenue growth and reduced G&A Expenses.
-
The company posted CA$184,000 in positive EBITDA in Q2 FY2022, compared to a loss of CA$507,000 in Q1 FY2022 and a loss of CA$1.6 million in Q2 FY2021. There was a one-time gain on settlement of CA$259,000 related to the redemption and cancellation of the preferred shares during Q2 FY2022.
As at May 31, 2022, the company had CA$1.26 million of cash and CA$1.03 million in receivables.
Ryan Smith, CFO, stated, “our financial results demonstrate that our business model is performing and that by focusing upon high-quality, consistent cannabis oil, we can continue to grow our top and bottom lines.”
Photo by Tim Foster on Unsplash
Related News
Canopy Growth & Other Cannabis Operators Just Made Some Key Executive Changes You Should Know About
Christina Lake Cannabis: Shares Up On Third-Quarter 495% Gross Revenue Growth QoQ
Cannabis And Hemp Producer Ovation Science To Debut On OTCQB Market
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.